A landmark shift is underway in Africa's health sector and the commercial opportunity it is creating for U.S. and African companies has never been greater. The African Medicines Agency, AfCFTA's health trade provisions, and regional harmonization initiatives are collectively building a more unified, predictable, and commercially attractive market architecture for pharmaceuticals and medical technologies across the continent. For U.S. and African companies ready to move, the timing could not be better. 

Regulatory convergence delivers tangible results: accelerated product registration, streamlined market entry, stronger supply chain integration, and a growing foundation for local manufacturing partnerships. For pharmaceutical and medical technology companies, this is not a compliance story - it is a market access story. A more harmonized African regulatory environment means larger addressable markets, lower entry costs and a significantly more compelling investment case. 

This panel brings together U.S. and African business leaders, health regulators, and investment partners to examine where harmonization is already generating commercial returns, showcase partnerships and investments that are leading the way and identify what governments and the private sector can do together to accelerate the next wave of U.S.-Africa health industry growth.